Clinical trial
Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With…
NCT00016913 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00016913 |
|---|---|
| Title | Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer |
| Official title | Phase II Study Of Neo-Adjuvant Paclitaxel, Estramustine And Carboplatin (TEC) Plus Androgen Ablation Prior To Radiation Therapy In Patients With Poor Prognosis Localized Prostate Cancer |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Radiation |
| Interventions | carboplatin, estramustine, paclitaxel, radiation therapy, leuprolide or goserelin acetate |
| Enrollment | 34 |
| Start date | May 1, 2001 |
| Primary completion | Jul 1, 2007 |
| Completion | May 1, 2008 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 6, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: